Long noncoding RNA SNHG12 integrates a DNA-PK-mediated DNA damage response and fascular senescence Preclinical Research, VitalityANAD StaffFebruary 19, 2020
DNA methylation changes are associated with the programming of white adipose tissue browning features by resveratrol and nicotinamide riboside neonatal supplementations in mice Preclinical Research, VitalityANAD StaffFebruary 12, 2020
Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of moduating NAD+ levels in hSOD2-linked ALS mouse models Preclinical Research, CognitionANAD StaffJanuary 31, 2020
Nicotinamide riboside rescues angiotensin II-induced cerebral small vessel disease in mice Preclinical Research, VitalityANAD StaffJanuary 14, 2020
Short-term NAD+ supplementation prevents hearing loss in mouse models of Cockayne syndrome Preclinical Research, SensoryANAD StaffJanuary 7, 2020
Nicotinamide riboside enhances mitochondrial proteostasis and adult neurogenesis through activationof mitochondrial unfolded protein response signaling in the brain of ALS SOD1 G93A mice Preclinical Research, CognitionANAD StaffJanuary 1, 2020
Nicotinamide pathway-dependent Sirt1 activation restores calcium homeostasis to achieve neuroprotection in Spinocerebellar Ataxia Type 7 Preclinical Research, LocomotionANAD StaffDecember 16, 2019
Nicotinamide riboside alleviates alcohol-induced depression-like behaviours in C57BL/6J mice by altering the intestinal microbiota associated with microglial activation and BDNF expression Preclinical Research, PsychologicalANAD StaffDecember 3, 2019
Degradation of Extracellular NAD+ intermediates in cultures of human HEK293 cells Preclinical Research, Basic ResearchANAD StaffNovember 29, 2019
NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome Preclinical Research, VitalityANAD StaffNovember 21, 2019
Understanding the physicochemical properties and degradation kinetics of nicotinamide riboside, a promising vitamin B3 nutritional supplement Preclinical Research, Pharmacokinetic/SafetyANAD StaffNovember 21, 2019
High dose of dietary nicotinamide riboside induces glucose intolerance and white adipose tissue dysfunction in mice fed a mildly obesogenic diet Preclinical Research, VitalityANAD StaffOctober 17, 2019
NAD+ repletion inhibits the endothelial-to-mesenchymal transition induced by TGF-ß in endothlial cells through improving mitochondrial unfolded protein response Preclinical Research, VitalityANAD StaffOctober 15, 2019
Rapid differentiation of the human RPE cell line, ARPE-19, induced by nicotinamide Preclinical Research, Basic ResearchANAD StaffOctober 15, 2019
The senotherapeutic nicotinamide riboside raises platelet nicotinamide adenine dinucleotide levels but cannot prevent storage lesion Preclinical Research, Basic ResearchANAD StaffSeptember 19, 2019
NAD+ precursor increases aerobic performance in mice Preclinical Research, LocomotionANAD StaffSeptember 7, 2019
Combined treatment with L-carnitine and nicotinamide riboside improves hepatic metabolism and attenuates obesity and liver steatosis Preclinical Research, VitalityANAD StaffSeptember 5, 2019
Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice Preclinical Research, VitalityANAD StaffAugust 28, 2019
Supplementation with nicotinamide riboside reduces brain inflammation and improves cognitive function in diabetic mice Preclinical Research, CognitionANAD StaffAugust 27, 2019
Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity Preclinical Research, VitalityANAD StaffJuly 18, 2019
